Acta Medica

Acta Medica

Genome Editing Technologies: From Bench Side to Bedside

Yazarlar: Fulya Yaylacıoğlu Tuncay, Pervin Rukiye Dinçer

Cilt 49 , Sayı 3 , 2018 , Sayfalar -

Konular:-

Anahtar Kelimeler: genome-editing,CRISPR/Cas9,Gene therapy

Özet: The development of genome editing technologies has given the chance to researchers to manipulate any genomic sequences precisely. This ability is very useful for creating animal models to study human diseases in vivo; for easy creation of isogenic cell lines to study in vitro and most importantly for overcoming many disadvantages that the researchers faced during the human gene therapy trials. Here we review the basic mechanisms of genome editing technology and the four genome-editing platforms. We also discuss the applications of these novel technologies in preclinical and clinical studies in four groups according to the mechanism used, and lastly, summarize the problems in these technologies.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2018, title={Genome Editing Technologies: From Bench Side to Bedside}, volume={49}, publisher={Acta Medica}, author={Fulya Yaylacıoğlu Tuncay, Pervin Rukiye Dinçer}, year={2018} }
APA
KOPYALA
Fulya Yaylacıoğlu Tuncay, Pervin Rukiye Dinçer. (2018). Genome Editing Technologies: From Bench Side to Bedside (Vol. 49). Vol. 49. Acta Medica.
MLA
KOPYALA
Fulya Yaylacıoğlu Tuncay, Pervin Rukiye Dinçer. Genome Editing Technologies: From Bench Side to Bedside. no., Acta Medica, 2018.